| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/23/2008 | EP1947185A1 HCV NS3/4A encoding nucleic acid |
| 07/23/2008 | EP1947183A1 Mammalian cell surface antigens; related reagents |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 07/23/2008 | EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent |
| 07/23/2008 | EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2008 | EP1947110A1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli |
| 07/23/2008 | EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase |
| 07/23/2008 | EP1946776A1 Stabilized TNFR-Fc composition comprising arginine |
| 07/23/2008 | EP1946775A2 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 07/23/2008 | EP1946774A1 Cerebral infarction-preventive agent |
| 07/23/2008 | EP1946773A2 Improved saponin adjuvant compositions and methods relating thereto |
| 07/23/2008 | EP1946772A1 Multivalent vaccine composition |
| 07/23/2008 | EP1946771A1 Multivalent vaccine composition |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1946769A2 Multivalent vaccine composition with reduced dose of Haemophilus influenzae type B |
| 07/23/2008 | EP1946768A1 Outer coat protein pa5158 of pseudomonas aeruginosa |
| 07/23/2008 | EP1946767A2 Autologous T-cell vaccines against multiple sclerosis |
| 07/23/2008 | EP1946748A1 Composition for administration to mammals or humans |
| 07/23/2008 | EP1946114A2 Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
| 07/23/2008 | EP1945819A2 Gene expression profiles and methods of use |
| 07/23/2008 | EP1945778A2 Multi-plasmid system for the production of influenza virus |
| 07/23/2008 | EP1945777A1 Expression system incorporating a capsid promotor sequence as an enhancer of a cytomegalovirus promotor |
| 07/23/2008 | EP1945771A1 Fusion proteins that bind effector lymphocytes and target cells |
| 07/23/2008 | EP1945767A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 07/23/2008 | EP1945674A2 Therapeutic anti-her2 antibody fusion polypeptides |
| 07/23/2008 | EP1945672A2 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis |
| 07/23/2008 | EP1945670A2 Therapeutic agent |
| 07/23/2008 | EP1945669A1 Chimeric antibodies with new world primate regions |
| 07/23/2008 | EP1945668A1 Engineered antibodies with new world primate framework regions |
| 07/23/2008 | EP1945666A2 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use |
| 07/23/2008 | EP1945665A2 Antibody-based therapeutics with enhanced adcc activity |
| 07/23/2008 | EP1945659A2 Influenza viruses able to infect canids, uses thereof |
| 07/23/2008 | EP1945264A2 Treatment for antiphospholipid-syndrome-related pregnancy complications |
| 07/23/2008 | EP1945262A2 Fc labeling for immunostaining and immunotargeting |
| 07/23/2008 | EP1945261A2 Compositions and methods for controlling tissue factor signaling specificity |
| 07/23/2008 | EP1945260A1 Uses of anti-cd40 antibodies |
| 07/23/2008 | EP1945258A2 Tdf-related compounds and analogs thereof |
| 07/23/2008 | EP1945257A2 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 07/23/2008 | EP1945255A2 Radiating element for radar array antenna |
| 07/23/2008 | EP1945254A1 Vaccines and methods to treat canine influenza |
| 07/23/2008 | EP1945253A2 Adminstration routes for priming/boosting with influenza vaccines |
| 07/23/2008 | EP1945252A1 Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| 07/23/2008 | EP1945251A1 Prime boost vaccine for the protection of equines against equine influenza |
| 07/23/2008 | EP1945250A2 Influenza recombinant subunit vaccine |
| 07/23/2008 | EP1945249A2 Compositions with antigens adsorbed to calcium phosphate |
| 07/23/2008 | EP1945248A2 Compositions and methods for the detection of trypanosoma cruzi infection |
| 07/23/2008 | EP1945247A1 Mucosal and systemic immunizations with alphavirus replicon particles |
| 07/23/2008 | EP1945246A2 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 07/23/2008 | EP1517692B1 Use of gangliosides for the prevention, inhibition and treatment of sepsis |
| 07/23/2008 | EP1335742B1 Use of peptides dervied from apoB100 in the production of a vaccine/diagnostic against atherosclerosis |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1320351B1 Methods of preparing immune globulin and uses thereof |
| 07/23/2008 | EP1270595B1 Anti ccr4 antibody and its fragment |
| 07/23/2008 | EP1163271B1 Recombinant il-18 antibodies and their use |
| 07/23/2008 | EP0970206B1 Lage-1 tumor associated nucleic acids |
| 07/23/2008 | EP0652772B2 Herpesvirus vaccines |
| 07/23/2008 | CN101228276A Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 07/23/2008 | CN101228188A IL-1β结合抗体及其片段 IL-1β binding antibodies and fragments |
| 07/23/2008 | CN101228187A Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses |
| 07/23/2008 | CN101228184A Variant polypeptide and screening assay |
| 07/23/2008 | CN101227924A Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| 07/23/2008 | CN101227923A Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue |
| 07/23/2008 | CN101227922A Compositions and methods for modulating cells via CD14 and toII-like receptor 4 signaling pathway |
| 07/23/2008 | CN101227921A Use of EphA4 and modulator of EphA4 for diagnosis, treatment and prevention of cancer |
| 07/23/2008 | CN101227920A Recombinant flu vaccines |
| 07/23/2008 | CN101227919A Peptide-based influenza vaccine formulation |
| 07/23/2008 | CN101226199A Effect of N-methyl-D-asparagic acid acceptor in epilepsy generation |
| 07/23/2008 | CN101225109A Tumour soluble antigen and staphylococcus aureus superantigen constructed tumor vaccine |
| 07/23/2008 | CN101224302A Real time individuation poultry egg antibody preparation for anti Hepatitis B or C virus and preparing method and application thereof |
| 07/23/2008 | CN101224301A Application of attenuated live vaccine virus in preparing AIDS and flu treatment medicine |
| 07/23/2008 | CN101224300A Application of colon bacillus OmpA as animal immunity regulator |
| 07/23/2008 | CN101224231A Method of extracting immunologic adjuvant component from cochinchina momordica seed |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404669C Novel reovirus, its antibody and vaccine and use thereof |
| 07/23/2008 | CN100404554C Antifish lymphocystis virus capsid protein monoclonal antibody, and its preparing method |
| 07/23/2008 | CN100404070C Packaged virus-like particles |
| 07/22/2008 | US7402727 Model produced by injecting an immunodeficient mouse with a suspension of single cells of human small cell lung carcinoma SBC-5 cells to effect metastasis in the mouse's own bone; used for screening anticancer drugs |
| 07/22/2008 | US7402666 Vaccine based on fact that a significant proportion of canine and feline tumours express an oncofetal leucine-rich glycoprotein, known as "5T4" |
| 07/22/2008 | US7402662 Antibody molecules specific to human tumor necrosis factor alpha |
| 07/22/2008 | US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein |
| 07/22/2008 | US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family |
| 07/22/2008 | US7402657 C-C chemokine receptor 3 proteins |
| 07/22/2008 | US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders |
| 07/22/2008 | US7402575 Methods of treating inflammation |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/22/2008 | US7402429 Stably transfected plasmids that express polymerase, viral proteins from measles or mumps; Paramyxoviridae; use in vaccines or gene therapy |
| 07/22/2008 | US7402427 Genomic RNA of paramyxovirus encoding M and F proteins; decreased production of viral particles; suppresses cancer growth |
| 07/22/2008 | US7402410 Humanized immunoglobulin reactive with α4β7 integrin |
| 07/22/2008 | US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/22/2008 | US7402385 Bind to cellular component released by a dying tumor cell; imaging melanin-containing melanomas; radioimmunotherapy |
| 07/22/2008 | US7402317 Culturing human cancer cells; purification, recovering of antigens |
| 07/22/2008 | US7402316 Group A streptococcal vaccines |
| 07/22/2008 | US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines |
| 07/22/2008 | US7402314 Antigen peptides; medical diagnosis |
| 07/22/2008 | US7402313 Calculating a suitable dosage of digoxin immune fab, administering by intravenous bolus and repeating |
| 07/22/2008 | US7402312 Immunoglobulin mixture specific to endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents |
| 07/22/2008 | US7402307 Method for identifying and killing cancer cells |